866-997-4948(US-Canada Toll Free)

Global Parkinsons Disease Drug Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Aug 2018

Category :

Pharmaceutical

No. of Pages : 102 Pages

This report studies the global market size of Parkinson's Disease Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Parkinson's Disease Drug in these regions.
This research report categorizes the global Parkinson's Disease Drug market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

In 2017, the global Parkinson's Disease Drug market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Parkinson's Disease Drug market based on company, product type, application and key regions.

The various contributors involved in the value chain of Parkinson's Disease Drug include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Parkinson's Disease Drug include
Merck
Akorn
GSK
Novartis
Boehringer Ingelheim
Teva Pharmaceutical
Abbvie
Kyowa Hakko Kirin Pharma
Astellas Pharma
Desitin Arzneimittel
Endo Pharmaceuticals
F.Hoffmann-La Roche
H.Lundbeck
Valeant
Apokyn
Orion
Stada Arzneimittel
US WorldMeds
Valeant Pharmaceuticals

Market Size Split by Type
Sinemet-CR
Trastal
Madopar
COMT Inhibitor
Other
Market Size Split by Application
Under 40 Years Old
40-65 Years Old
Above 65 Years Old

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Parkinson's Disease Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Parkinson's Disease Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Parkinson's Disease Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Parkinson's Disease Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Parkinson's Disease Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Parkinson's Disease Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Parkinson's Disease Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Parkinson's Disease Drug Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Parkinson's Disease Drug Market Size Growth Rate by Type
1.4.2 Sinemet-CR
1.4.3 Trastal
1.4.4 Madopar
1.4.5 COMT Inhibitor
1.4.6 Other
1.5 Market by Application
1.5.1 Global Parkinson's Disease Drug Market Size Growth Rate by Application
1.5.2 Under 40 Years Old
1.5.3 40-65 Years Old
1.5.4 Above 65 Years Old
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Parkinson's Disease Drug Market Size
2.1.1 Global Parkinson's Disease Drug Revenue 2016-2025
2.1.2 Global Parkinson's Disease Drug Sales 2016-2025
2.2 Parkinson's Disease Drug Growth Rate by Regions
2.2.1 Global Parkinson's Disease Drug Sales by Regions
2.2.2 Global Parkinson's Disease Drug Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Parkinson's Disease Drug Sales by Manufacturers
3.1.1 Parkinson's Disease Drug Sales by Manufacturers
3.1.2 Parkinson's Disease Drug Sales Market Share by Manufacturers
3.1.3 Global Parkinson's Disease Drug Market Concentration Ratio (CR5 and HHI)
3.2 Parkinson's Disease Drug Revenue by Manufacturers
3.2.1 Parkinson's Disease Drug Revenue by Manufacturers (2016-2018)
3.2.2 Parkinson's Disease Drug Revenue Share by Manufacturers (2016-2018)
3.3 Parkinson's Disease Drug Price by Manufacturers
3.4 Parkinson's Disease Drug Manufacturing Base Distribution, Product Types
3.4.1 Parkinson's Disease Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Parkinson's Disease Drug Product Category
3.4.3 Date of International Manufacturers Enter into Parkinson's Disease Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Parkinson's Disease Drug Sales by Type
4.2 Global Parkinson's Disease Drug Revenue by Type
4.3 Parkinson's Disease Drug Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Parkinson's Disease Drug Breakdown Data by Application

6 North America
6.1 North America Parkinson's Disease Drug by Countries
6.1.1 North America Parkinson's Disease Drug Sales by Countries
6.1.2 North America Parkinson's Disease Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Parkinson's Disease Drug by Type
6.3 North America Parkinson's Disease Drug by Application
6.4 North America Parkinson's Disease Drug by Company

7 Europe
7.1 Europe Parkinson's Disease Drug by Countries
7.1.1 Europe Parkinson's Disease Drug Sales by Countries
7.1.2 Europe Parkinson's Disease Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Parkinson's Disease Drug by Type
7.3 Europe Parkinson's Disease Drug by Application
7.4 Europe Parkinson's Disease Drug by Company

8 Asia Pacific
8.1 Asia Pacific Parkinson's Disease Drug by Countries
8.1.1 Asia Pacific Parkinson's Disease Drug Sales by Countries
8.1.2 Asia Pacific Parkinson's Disease Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Parkinson's Disease Drug by Type
8.3 Asia Pacific Parkinson's Disease Drug by Application
8.4 Asia Pacific Parkinson's Disease Drug by Company

9 Central & South America
9.1 Central & South America Parkinson's Disease Drug by Countries
9.1.1 Central & South America Parkinson's Disease Drug Sales by Countries
9.1.2 Central & South America Parkinson's Disease Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Parkinson's Disease Drug by Type
9.3 Central & South America Parkinson's Disease Drug by Application
9.4 Central & South America Parkinson's Disease Drug by Company

10 Middle East and Africa
10.1 Middle East and Africa Parkinson's Disease Drug by Countries
10.1.1 Middle East and Africa Parkinson's Disease Drug Sales by Countries
10.1.2 Middle East and Africa Parkinson's Disease Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Parkinson's Disease Drug by Type
10.3 Middle East and Africa Parkinson's Disease Drug by Application
10.4 Middle East and Africa Parkinson's Disease Drug by Company

11 Company Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Parkinson's Disease Drug
11.1.4 Parkinson's Disease Drug Product Description
11.1.5 Recent Development
11.2 Akorn
11.2.1 Akorn Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Parkinson's Disease Drug
11.2.4 Parkinson's Disease Drug Product Description
11.2.5 Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Parkinson's Disease Drug
11.3.4 Parkinson's Disease Drug Product Description
11.3.5 Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Parkinson's Disease Drug
11.4.4 Parkinson's Disease Drug Product Description
11.4.5 Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Parkinson's Disease Drug
11.5.4 Parkinson's Disease Drug Product Description
11.5.5 Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Parkinson's Disease Drug
11.6.4 Parkinson's Disease Drug Product Description
11.6.5 Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Parkinson's Disease Drug
11.7.4 Parkinson's Disease Drug Product Description
11.7.5 Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Parkinson's Disease Drug
11.8.4 Parkinson's Disease Drug Product Description
11.8.5 Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Parkinson's Disease Drug
11.9.4 Parkinson's Disease Drug Product Description
11.9.5 Recent Development
11.10 Desitin Arzneimittel
11.10.1 Desitin Arzneimittel Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Parkinson's Disease Drug
11.10.4 Parkinson's Disease Drug Product Description
11.10.5 Recent Development
11.11 Endo Pharmaceuticals
11.12 F.Hoffmann-La Roche
11.13 H.Lundbeck
11.14 Valeant
11.15 Apokyn
11.16 Orion
11.17 Stada Arzneimittel
11.18 US WorldMeds
11.19 Valeant Pharmaceuticals

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Parkinson's Disease Drug Raw Material
13.1.2 Parkinson's Disease Drug Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Parkinson's Disease Drug
Figure Global Parkinson's Disease Drug Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Parkinson's Disease Drug Production Market Share by Types (Product Category) in 2017
Figure Sinemet-CR Product Picture
Table Major Manufacturers of Sinemet-CR
Figure Trastal Product Picture
Table Major Manufacturers of Trastal
Figure Madopar Product Picture
Table Major Manufacturers of Madopar
Figure COMT Inhibitor Product Picture
Table Major Manufacturers of COMT Inhibitor
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Parkinson's Disease Drug Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Under 40 Years Old
Figure 40-65 Years Old
Figure Above 65 Years Old
Figure Parkinson's Disease Drug Report Years Considered
Figure Global Parkinson's Disease Drug Market Size 2016-2025 (Million US$)
Figure Global Parkinson's Disease Drug Sales 2016-2025 (K Units)
Table Global Parkinson's Disease Drug Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Parkinson's Disease Drug Sales by Regions 2016-2025 (K Units)
Table Global Parkinson's Disease Drug Sales Market Share by Regions 2016-2025
Figure Global Parkinson's Disease Drug Sales Market Share by Regions 2016-2025
Figure 2017 Global Parkinson's Disease Drug Sales Market Share by Regions
Table Global Parkinson's Disease Drug Revenue by Regions 2016-2025 (Million US$)
Table Global Parkinson's Disease Drug Revenue Market Share by Regions 2016-2025
Figure Global Parkinson's Disease Drug Revenue Market Share by Regions 2016-2025
Figure 2017 Global Parkinson's Disease Drug Revenue Market Share by Regions
Table Global Parkinson's Disease Drug Sales by Manufacturers (2016-2018) (K Units)
Table Global Parkinson's Disease Drug Sales Share by Manufacturers (2016-2018)
Figure Global Parkinson's Disease Drug Sales Share by Manufacturers in 2017
Table Parkinson's Disease Drug Revenue by Manufacturers (2016-2018) (Million US$)
Table Parkinson's Disease Drug Revenue Share by Manufacturers (2016-2018)
Figure Parkinson's Disease Drug Value Share by Manufacturers in 2017
Table Global Parkinson's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Parkinson's Disease Drug Price (2016-2018) (USD/Unit)
Table Parkinson's Disease Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Parkinson's Disease Drug Product Category
Table Date of International Manufacturers Enter into Parkinson's Disease Drug Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Parkinson's Disease Drug Sales by Type (2016-2025) (K Units)
Table Global Parkinson's Disease Drug Sales Share by Type (2016-2025)
Figure Global Parkinson's Disease Drug Sales Market Share by Type (2016-2025)
Figure Global Parkinson's Disease Drug Sales Market Share by Type in 2017
Table Global Parkinson's Disease Drug Revenue by Type (2016-2025) (Million US$)
Table Global Parkinson's Disease Drug Revenue Share by Type (2016-2025)
Figure Global Parkinson's Disease Drug Revenue Market Share by Type (2016-2025)
Figure Global Parkinson's Disease Drug Revenue Market Share by Type in 2017
Table Parkinson's Disease Drug Price by Type 2013-2018 (USD/Unit)
Table Global Parkinson's Disease Drug Sales by Application (2016-2025) (K Units)
Table Global Parkinson's Disease Drug Sales Share by Application (2016-2025)
Figure Global Sales Parkinson's Disease Drug Market Share by Application (2016-2025)
Figure Global Sales Parkinson's Disease Drug Market Share by Application (2016-2025)
Figure North America Parkinson's Disease Drug Sales Growth Rate 2016-2025 (K Units)
Figure North America Parkinson's Disease Drug Revenue Growth Rate 2016-2025 (Million US$)
Table North America Parkinson's Disease Drug Sales by Countries (2016-2025) (K Units)
Table North America Parkinson's Disease Drug Sales Market Share by Countries (2016-2025)
Figure 2017 North America Parkinson's Disease Drug Sales Market Share by Countries
Table North America Parkinson's Disease Drug Revenue by Countries (2016-2025) (Million US$)
Table North America Parkinson's Disease Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Parkinson's Disease Drug Revenue Market Share by Countries
Figure United States Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure United States Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Canada Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Table North America Parkinson's Disease Drug Sales by Type (2016-2025) (K Units)
Table North America Parkinson's Disease Drug Sales Market Share by Type (2016-2025)
Figure 2017 North America Parkinson's Disease Drug Market Share by Type
Table North America Parkinson's Disease Drug Sales by Application (2016-2025) (K Units)
Table North America Parkinson's Disease Drug Sales Market Share by Application (2016-2025)
Figure 2017 North America Parkinson's Disease Drug Market Share by Application
Table North America Parkinson's Disease Drug Sales by Company (2016-2018) (K Units)
Table North America Parkinson's Disease Drug Sales Market Share by Company (2016-2018)
Figure North America Parkinson's Disease Drug Sales Market Share by Company in 2017
Figure Europe Parkinson's Disease Drug Sales Growth Rate 2016-2025 (K Units)
Figure Europe Parkinson's Disease Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Parkinson's Disease Drug Sales by Countries (2016-2025) (K Units)
Table Europe Parkinson's Disease Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Parkinson's Disease Drug Sales Market Share by Countries
Table Europe Parkinson's Disease Drug Revenue by Countries (2016-2025) (Million US$)
Table Europe Parkinson's Disease Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Parkinson's Disease Drug Revenue Market Share by Countries
Figure Germany Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Germany Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (K Units)
Figure France Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure France Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (K Units)
Figure UK Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure UK Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Italy Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Russia Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Parkinson's Disease Drug Sales by Type (2016-2025) (K Units)
Table Europe Parkinson's Disease Drug Sales Market Share by Type (2016-2025)
Figure 2017 Europe Parkinson's Disease Drug Market Share by Type
Table Europe Parkinson's Disease Drug Sales by Application (2016-2025) (K Units)
Table Europe Parkinson's Disease Drug Sales Market Share by Application (2016-2025)
Figure 2017 Europe Parkinson's Disease Drug Market Share by Application
Table Europe Parkinson's Disease Drug Sales by Company (2016-2018) (K Units)
Table Europe Parkinson's Disease Drug Sales Market Share by Company (2016-2018)
Figure Europe Parkinson's Disease Drug Sales Market Share by Company in 2017
Figure Asia Pacific Parkinson's Disease Drug Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Parkinson's Disease Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Parkinson's Disease Drug Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Parkinson's Disease Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Parkinson's Disease Drug Sales Market Share by Countries
Table Asia Pacific Parkinson's Disease Drug Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Parkinson's Disease Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Parkinson's Disease Drug Revenue Market Share by Countries
Figure China Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure China Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Japan Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Korea Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure India Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure India Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Australia Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Parkinson's Disease Drug Sales by Type (2016-2025) (K Units)
Table Asia Pacific Parkinson's Disease Drug Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Parkinson's Disease Drug Market Share by Type
Table Asia Pacific Parkinson's Disease Drug Sales by Application (2016-2025) (K Units)
Table Asia Pacific Parkinson's Disease Drug Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Parkinson's Disease Drug Market Share by Application
Table Asia Pacific Parkinson's Disease Drug Sales by Company (2016-2018) (K Units)
Table Asia Pacific Parkinson's Disease Drug Sales Market Share by Company (2016-2018)
Figure Asia Pacific Parkinson's Disease Drug Sales Market Share by Company in 2017
Figure Central & South America Parkinson's Disease Drug Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Parkinson's Disease Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Parkinson's Disease Drug Sales by Countries (2016-2025) (K Units)
Table Central & South America Parkinson's Disease Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Parkinson's Disease Drug Sales Market Share by Countries
Table Central & South America Parkinson's Disease Drug Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Parkinson's Disease Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Parkinson's Disease Drug Revenue Market Share by Countries
Figure Brazil Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Parkinson's Disease Drug Sales by Type (2016-2025) (K Units)
Table Central & South America Parkinson's Disease Drug Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Parkinson's Disease Drug Market Share by Type
Table Central & South America Parkinson's Disease Drug Sales by Application (2016-2025) (K Units)
Table Central & South America Parkinson's Disease Drug Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Parkinson's Disease Drug Market Share by Application
Table Central & South America Parkinson's Disease Drug Sales by Company (2016-2018) (K Units)
Table Central & South America Parkinson's Disease Drug Sales Market Share by Company (2016-2018)
Figure Central & South America Parkinson's Disease Drug Sales Market Share by Company in 2017
Figure Middle East and Africa Parkinson's Disease Drug Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Parkinson's Disease Drug Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Parkinson's Disease Drug Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Parkinson's Disease Drug Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Parkinson's Disease Drug Sales Market Share by Countries
Table Middle East and Africa Parkinson's Disease Drug Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Parkinson's Disease Drug Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Parkinson's Disease Drug Revenue Market Share by Countries
Figure GCC Countries Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Parkinson's Disease Drug Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Parkinson's Disease Drug Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Parkinson's Disease Drug Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Parkinson's Disease Drug Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Parkinson's Disease Drug Market Share by Type
Table Middle East and Africa Parkinson's Disease Drug Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Parkinson's Disease Drug Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Parkinson's Disease Drug Market Share by Application
Table Middle East and Africa Parkinson's Disease Drug Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Parkinson's Disease Drug Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Parkinson's Disease Drug Sales Market Share by Company in 2017
Table Merck Company Details
Table Merck Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck Recent Development
Table Akorn Company Details
Table Akorn Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Akorn Recent Development
Table GSK Company Details
Table GSK Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GSK Recent Development
Table Novartis Company Details
Table Novartis Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Boehringer Ingelheim Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Teva Pharmaceutical Recent Development
Table Abbvie Company Details
Table Abbvie Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Abbvie Recent Development
Table Kyowa Hakko Kirin Pharma Company Details
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Kyowa Hakko Kirin Pharma Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Astellas Pharma Recent Development
Table Desitin Arzneimittel Company Details
Table Desitin Arzneimittel Parkinson's Disease Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Desitin Arzneimittel Recent Development
Table Endo Pharmaceuticals Company Details
Table F.Hoffmann-La Roche Company Details
Table H.Lundbeck Company Details
Table Valeant Company Details
Table Apokyn Company Details
Table Orion Company Details
Table Stada Arzneimittel Company Details
Table US WorldMeds Company Details
Table Valeant Pharmaceuticals Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Parkinson's Disease Drug Value Chain
Table Typical Suppliers of Key Parkinson's Disease Drug Raw Material
Table Parkinson's Disease Drug Customers List
Table Parkinson's Disease Drug Sales Channels
Table Parkinson's Disease Drug Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *